Last reviewed · How we verify

NCT05801965

A Digital Therapeutic Solution for Cancer Patients

Completed NA Last updated 25 May 2025
What this trial tests

NA trial testing A digital solution for patients with Cancer in Cancer in 48 participants. Completed in 1 September 2024.

Timeline
6 April 2023
Primary endpoint
1 September 2024
1 September 2024

Quick facts

Lead sponsorSidekick Health
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment48
Start date6 April 2023
Primary completion1 September 2024
Estimated completion1 September 2024
Sites2 locations across Iceland

Drugs / interventions tested

Conditions studied

Sponsor

Sidekick Health

Who can join

18 and older, any sex, with Cancer or Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized, controlled trial to assess the feasibility of Sidekick Health's digital programs for cancer patients. Participants will be treated with standard of care (SoC) in combination with the digital programs, or SoC only. We will compare the effect of the digital programs in addition to SoC to SoC only, on the cancer-related quality of life (QoL), cancer-related fatigue, and side-effect management.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Sidekick Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05801965.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing